Jyoti Burruss is a Dermatology physician affiliated with University of Louisville. OpenAlex indexes 13 publications with 264 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3810 Springhurst Blvd
Suite 200
Louisville, KY 40241
Telephone
502-583-1749Registry record last updated 17 Jul 2018.
Industry payments
31 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202525 payments
- UCB, Inc.Program year20259 payments
- Janssen Biotech, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
67.3%Porphyrin Precursor62.4%Aminolevulinic acid hcl100%Part B, office-administered≥11 patientsFolate Analog Metabolic Inhibitor2.5%Methotrexate100%Part D≥31 patients+ 5 more classes in this area
Dermatology
10.3%Corticosteroid9.3%Triamcinolone acetonide58%Triamcinolone Acetonide42%Part D + Part B≥157 patientsRetinoid0.4%Acitretin100%Part D<11 patients+ 2 more classes in this area
Anti-infectives
7.3%Azole Antifungal4.4%Ketoconazole100%Part D≥141 patientsNitroimidazole Antimicrobial1.1%Metronidazole100%Part D≥40 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 33696 Dyschromatosis symmetrica hereditaria disguised as lentigines
Journal of the American Academy of Dermatology
2022 - 33696 Dyschromatosis symmetrica hereditaria disguised as lentigines
Journal of the American Academy of Dermatology
2022 - Hydroxyurea-Associated Dermatomyositis-like Eruption Demonstrating Abnormal Epidermal p53 Expression
Archives of Dermatology
2010
Similar KOLs
Other experts from the same institution or the same specialty.
Kelly McMasters, MD
University of Louisville
Stephen McClave, MD
University of Louisville
Robert Friedland, MD
University of Louisville
Charles Scoggins, MD
University of Louisville
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”